Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1–50 of 75301
On July 7, 2026, Park Aerospace Corp. terminated the employment of Cory Nickel, Senior Vice President and General Manager of the Company, effective immediately.
Also on July 7, 2026, the Company appointed John Jamieson, age 65, as Senior Vice President and General Manager of the Company, effective immediately.
On July 9, 2026, the Board of Directors (the “ Board ”) of FuboTV Inc. (the “ Company ”) appointed Alisa Bowen as Chief Executive Officer of the Company, effective July 10, 2026.
On July 8, 2026, Nathaniel Fick resigned from his role as a Class III director of the Board, effective July 8, 2026, to accept an appointment as preferred stock director of the Board.
On July 9, 2026, the Board appointed Haiyan Song, age 60, to the Board.
Nathaniel Fick will succeed Mr. Nixon as a preferred stock director of the Board, effective July 8, 2026.
On July 8, 2026, Greg Nixon resigned from his role as a preferred stock director of the Board of Directors (the “Board”) of Eos Energy Enterprises, Inc. (the “Company”), effective July 8, 2026, to devote more time to other business ventures.
Mr. Bird will assume the Chief Financial Officer role from Karen L. Sedgwick, who has been appointed as the Chief Executive Officer and President of Southern California Gas Company, a subsidiary of Sempra, with an effective date concurrent with the effective date of Mr. Bird’s appointment as described above.
On July 6, 2026, the Board of Directors of Sempra appointed Justin C. Bird as Executive Vice President and Chief Financial Officer of Sempra, effective on a to-be-determined date on or around the closing of Sempra’s planned sale of a portion of its equity interest in Sempra Infrastructure Partners, LP, which is expected to occur in the third quarter of 2026.
Effective as of August 6, 2026, the Company has promoted Scott Jakalow, Vice President, SEC Reporting, Technical Accounting and Revenue, as the Company’s Chief Accounting Officer.
On July 2, 2026, Austin Kaplicer, Chief Accounting Officer and principal accounting officer of Angi Inc. (the “Company”), notified the Company of his decision to resign, effective as of August 6, 2026.
Effective as of August 6, 2026, the Company’s board of directors has designated Julie Hoarau, the Company’s Chief Financial Officer and principal financial officer, as the Company’s principal accounting officer.
Effective July 9, 2026, the employment of Mr. Kirk D. Jensen with the registrant and its wholly owned subsidiary First Interstate Bank as Executive Vice President and General Counsel/Corporate Secretary was terminated involuntarily and without cause
the directors of Merger Sub immediately prior to the Effective Time, Joseph Bernardello, Peter Limeri and Taylor Curtis, became the directors of the Surviving Corporation.
the directors of Merger Sub immediately prior to the Effective Time, Joseph Bernardello, Peter Limeri and Taylor Curtis, became the directors of the Surviving Corporation.
the directors of Merger Sub immediately prior to the Effective Time, Joseph Bernardello, Peter Limeri and Taylor Curtis, became the directors of the Surviving Corporation.
On July 8, 2026, Paul Grewal notified Coinbase Global, Inc. (“Coinbase” or the “Company”) of his intention to step down as Chief Legal Officer and Secretary of Coinbase, effective July 31, 2026.
the Company expects to appoint Molly Abraham, Vice President, Legal as the Company’s General Counsel and Secretary.
On July 7, 2026, Daniel R. Kozlowski notified the Board of Directors (the “ Board ”) of the Registrant of his resignation from the Board, effective immediately.
On July 2, 2026, Matt Link notified FibroBiologics, Inc. (the “Company”) that he was resigning from the Board of Directors (the “Board”), effective as of July 2, 2026.
On July 8, 2026, the Board appointed Kathleen Rubins, Ph.D. as a Class III director of the Board, effective July 8, 2026, to serve until the expiration of her term at the 2029 annual meeting of stockholders.
On July 2, 2026, Mike Schmidt notified Nixxy, Inc. (the "Company") of his decision to resign as Chief Executive Officer of the Company and as a member of the Company's Board of Directors (the "Board"), effective immediately.
On July 2, 2026, the Board appointed David Kratochvil, age 60, who currently serves as a member of the Board, as the Company's Chief Executive Officer.
On July 6, 2026, the Board appointed Ms. Kristina Campbell (“Ms. Campbell”) to serve as a member of the Board, effective immediately.
Mr. Caridi will remain with the Company as Senior Vice President, Business Transformation through his expected retirement on April 30, 2027 and will assist with the transition of his prior responsibilities to Mr. Scognamiglio.
Effective July 9, 2026, John Wiley & Sons, Inc. (the "Company") the Company appointed Frank Scognamiglio as Corporate Vice President, Chief Accounting Officer, to serve as the Company's principal accounting officer, succeeding Christopher Caridi, the Company’s former Chief Accounting Officer.
On July 9, 2026, Enovix Corporation (the “Company”) announced that it is appointing Dr. Michael Vyvoda as Chief Operating Officer of the Company, effective July 29, 2026 (the “Effective Date”).
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.
Peter Ort resigned as Chief Executive Officer and Co-Chairman
Jeff Tuder resigned as Chief Financial Officer and Co-Chairman
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
each of Robert Neal, Mark Smith and Eduardo Munemori ceased to be a director of RAAQ
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
Jane Novak ceased to be Chief Financial Officer
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
Brandon G. Lutnick ceased to be Chairman and Chief Executive Officer
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
the following individuals also ceased to be directors: Danny H. Salinas, Robert G. Sharp, Louis Zurita and Dr. Mukesh Prasad.
On July 1, 2026, 374Water Inc. (the “ Company ”) appointed Charles Weiser as Chief Financial Officer (“ CFO ”) of the Company, effective July 1, 2026 (the “ Effective Date ”).
Mr. Richard Soloway, currently Chairman and Chief Executive Officer, will serve as Founder and Executive Chairman
Mr. Kevin Buchel, currently President and Chief Operating Officer, will serve as Chief Executive Officer and President
On July 8, 2026, Ultra Clean Holdings, Inc. (the “Company”) announced that Michael Keogh will become the Company’s next Chief Financial Officer, effective August 5, 2026.
On July 1, 2026, Karen Ferrante, M.D. provided notice to the board of directors (the “Board”) of MacroGenics, Inc. (the “Company”) of her decision to resign from the Board, effective September 1, 2026.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.